Immune Responses After Vaccination With Primary 2-Dose ChAdOx1 Plus a Booster of BNT162b2 or Vaccination With Primary 2-Dose BNT162b2 Plus a Booster of BNT162b2 and the Occurrence of Omicron Breakthrough Infection
CONCLUSION: The cellular and humoral immune responses were low in the CCB group so that the breakthrough infection occurred faster in the CCB group than in the BBB group.PMID:37218354 | PMC:PMC10202617 | DOI:10.3346/jkms.2023.38.e155
Source: Journal of Korean Medical Science - Category: Biomedical Science Authors: Seong-Ho Choi Ji Young Park Oh Joo Kweon Joung Ha Park Min-Chul Kim Yaeji Lim Jin-Won Chung Source Type: research
More News: AstraZeneca | Biomedical Science | Coronavirus | Covid Vaccine | COVID-19 | Health Management | Pfizer | Respiratory Medicine | SARS | Science | Vaccines